Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04715724 · ClinicalTrials.gov registry record · NA

Comparison of Baby Dolls for Teaching Newborn Positioning and Attachment

A NA study, sponsored by LiquidGoldConcept.

Completed
Registry status
NA
Development phase
124
Enrollment target

NCT04715724: Completed NA study, sponsored by LiquidGoldConcept.

NCT04715724 is a NA study that has completed, run by LiquidGoldConcept. The registered enrollment target is 124 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04715724, a NA study, has completed, sponsored by LiquidGoldConcept.

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target

Study Summary

In this baby doll comparison study, clinical lactation specialists will complete two back-to-back video-based simulations (telesimulations) focused on newborn positioning and attachment. Study participants will interact with a standardized patient educator (SP) wearing the Lactation Simulation Model and using two baby dolls in a randomized order.

Primary Outcome

Participants will confirm or deny whether they were able to teach specific components of newborn positioning and attachment with the baby doll.

Interventions

  • OTHER Positioning and Attachment video-based simulation (telesimulation)

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2021-02-01
Est. Completion 2021-04-01
Phase NA
LiquidGoldConcept

2 total trials

What the finished NCT04715724 record still lists

NCT04715724 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Positioning and Attachment video-based simulation (telesimulation) is the first listed.

NCT04715724 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04715724 about?

NCT04715724 is a clinical study titled "Comparison of Baby Dolls for Teaching Newborn Positioning and Attachment". In this baby doll comparison study, clinical lactation specialists will complete two back-to-back video-based simulations (telesimulations) focused on newborn positioning and attachment. Study participants will interact with a standardized patient educator (SP) wearing the Lactation Simulation Model...

What is the current status of trial NCT04715724?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2021-02-01. Estimated completion is 2021-04-01.

What interventions are being tested in trial NCT04715724?

The interventions under investigation include: Positioning and Attachment video-based simulation (telesimulation) (OTHER).

Who is sponsoring clinical trial NCT04715724?

This trial is sponsored by LiquidGoldConcept, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04715724's enrollment target sits among peer trials

124 758th of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523014 · 124 participants · Phase 2

    Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  • NCT02670707 · 124 participants · Phase 3

    Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

  • NCT02830724 · 124 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

  • NCT04748809 · 124 participants · NA

    Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04715724, the US trial registry maintained by the National Library of Medicine. NCT04715724 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.